Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vbi Vaccines Inc CS
(NQ:
VBIV
)
0.0653
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0653
Bid (Size)
0.0450 (157)
Ask (Size)
0.0488 (112)
Prev. Close
0.0653
Today's Range
0.0653 - 0.0653
52wk Range
0.0553 - 1.350
Shares Outstanding
28,682,275
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 07, 2024
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
Via
InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
August 07, 2024
Via
Benzinga
Performance
YTD
-89.40%
-89.40%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-89.17%
-89.17%
1 Year
-90.25%
-90.25%
More News
Read More
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
August 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is VBI Vaccines (VBIV) Stock Up 62% Today?
August 06, 2024
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 06, 2024
Via
InvestorPlace
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
August 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Tumbles 950 Points; ISM Services PMI Surges In July
August 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
August 05, 2024
Via
Benzinga
VBI Vaccines Provides an Update on its Restructuring Proceedings
August 02, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
July 30, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Results of Annual General Meeting
June 25, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
May 29, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
May 22, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Via
InvestorPlace
VBI Vaccines Reports First Quarter 2024 Financial Results
May 15, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
April 16, 2024
Via
InvestorPlace
VBI Vaccines Reports Full Year 2023 Financial Results
April 16, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 11, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 09, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
April 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 05, 2024
Via
InvestorPlace
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
April 03, 2024
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
April 02, 2024
From
VBI Vaccines Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.